Pawel Zolnierczyk
Fondateur chez Iqure Pharma, Inc.
Profil
Pawel Zolnierczyk is the founder of Incanthera Oncology Ltd.
(2011).
He is also the founder of iQure Pharma Inc. Currently, Mr. Zolnierczyk holds the position of Director at Incanthera Oncology Ltd.
and Chief Operating Officer at Incanthera Research & Development Ltd.
In the past, he worked as a Manager-IP at the University of Salford and as the Chief Operating Officer at Incanthera Plc (2017-2022).
Mr. Zolnierczyk completed his undergraduate degree at Politechnika Gdanska.
Postes actifs de Pawel Zolnierczyk
| Sociétés | Poste | Début |
|---|---|---|
Incanthera Research & Development Ltd.
 Incanthera Research & Development Ltd. Medical DistributorsDistribution Services Incanthera Research & Development Ltd. develops drug delivery solutions for solid tumor chemotherapy. It offers cancer therapies, such as ICT01-2588, a vascular disrupting agent and drug delivery platform for lung and prostate cancer; and ICT03-Es5, a bioreductive anticancer agent for lung, liver, and breast cancer. The company was founded by Alan McGowan, Paul Loadman, Laurence Patterson, Andrew John Michael Duley, John Anthony Hadfield, Robert Falconer, and Jason Gill in 2010 and is headquartered in Manchester, the United Kingdom. | Directeur des opérations | - |
Incanthera Oncology Ltd.
 Incanthera Oncology Ltd. Medical DistributorsDistribution Services Incanthera Oncology Ltd. engages in the provision of drug development services. The company was founded on April 7, 2011 and is headquartered in Manchester, the United kingdom. | Directeur/Membre du Conseil | 01/09/2012 |
Iqure Pharma, Inc.
 Iqure Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Iqure Pharma, Inc. is a biotech company that develops therapeutics for patients and physicians. The company is based in Wilmington, DE. The company was founded by Pawel Zolnierczyk, Henk de Wilde, Peter Schiemann, Anna Rzewuska. Pawel Zolnierczyk has been the CEO since incorporation. | Fondateur | - |
Anciens postes connus de Pawel Zolnierczyk
| Sociétés | Poste | Fin |
|---|---|---|
Incanthera Plc
 Incanthera Plc Pharmaceuticals: MajorHealth Technology Incanthera Plc operates as a holding company, which focuses on drug discovery and development of targeted medicines for the treatment of cancer. The firm products include Sol, EP0015, Equin & Duo-C. The company was founded on March 2, 2010 and is headquartered in Manchester, the United Kingdom. | Directeur des opérations | 01/08/2022 |
| University of Salford | Corporate Officer/Principal | - |
Incanthera Oncology Ltd.
Incanthera Oncology Ltd. Medical DistributorsDistribution Services Incanthera Oncology Ltd. engages in the provision of drug development services. The company was founded on April 7, 2011 and is headquartered in Manchester, the United kingdom. | Fondateur | - |
Formation de Pawel Zolnierczyk
| Politechnika Gdanska | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |
| Entreprise privées | 3 |
|---|---|
Incanthera Research & Development Ltd.
Incanthera Research & Development Ltd. Medical DistributorsDistribution Services Incanthera Research & Development Ltd. develops drug delivery solutions for solid tumor chemotherapy. It offers cancer therapies, such as ICT01-2588, a vascular disrupting agent and drug delivery platform for lung and prostate cancer; and ICT03-Es5, a bioreductive anticancer agent for lung, liver, and breast cancer. The company was founded by Alan McGowan, Paul Loadman, Laurence Patterson, Andrew John Michael Duley, John Anthony Hadfield, Robert Falconer, and Jason Gill in 2010 and is headquartered in Manchester, the United Kingdom. | Distribution Services |
Incanthera Oncology Ltd.
Incanthera Oncology Ltd. Medical DistributorsDistribution Services Incanthera Oncology Ltd. engages in the provision of drug development services. The company was founded on April 7, 2011 and is headquartered in Manchester, the United kingdom. | Distribution Services |
Iqure Pharma, Inc.
Iqure Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Iqure Pharma, Inc. is a biotech company that develops therapeutics for patients and physicians. The company is based in Wilmington, DE. The company was founded by Pawel Zolnierczyk, Henk de Wilde, Peter Schiemann, Anna Rzewuska. Pawel Zolnierczyk has been the CEO since incorporation. | Commercial Services |